HomeLUNG • NASDAQ
Pulmonx Corp
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 22.54M | 19.54% |
Operating expense | 30.91M | 8.01% |
Net income | -14.45M | -5.08% |
Net profit margin | -64.11 | 12.08% |
Earnings per share | -0.36 | 0.00% |
EBITDA | -14.29M | -1.22% |
Effective tax rate | -0.94% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 88.70M | -23.62% |
Total assets | 150.74M | -8.41% |
Total liabilities | 73.07M | 35.10% |
Total equity | 77.67M | — |
Shares outstanding | 40.26M | — |
Price to book | 1.36 | — |
Return on assets | -23.22% | — |
Return on capital | -26.30% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -14.45M | -5.08% |
Cash from operations | -13.22M | -12.10% |
Cash from investing | 16.31M | 750.70% |
Cash from financing | 664.00K | -23.15% |
Net change in cash | 3.65M | 127.26% |
Free cash flow | -8.90M | -26.90% |
Previous close
$2.62
Day range
$2.51 - $2.63
Year range
$2.51 - $9.37
Market cap
102.66M USD
Avg Volume
354.70K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1995
Headquarters
Website
Employees
291